Lampros Papadimitriou, MD, PhD
Basic profileUniversity of Mississippi Medical Center
Lampros Papadimitriou is a Cardiology physician affiliated with University of Mississippi Medical Center. OpenAlex indexes 29 publications with 357 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2500 N State St
Jackson, MS 392164500
Telephone
601-815-1264Registry record last updated 2 Jul 2018.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20254 payments
- Merck Sharp & Dohme LLCProgram year20257 payments
- PFIZER INC.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.1%Beta blocker12.7%Carvedilol53%Metoprolol Succinate40%Metoprolol Tartrate7%Part D<11 patientsLoop diuretic10.8%Furosemide72%Torsemide21%Bumetanide8%Part D≥101 patients+ 16 more classes in this area
Metabolism & gastrointestinal
17.2%SGLT2 inhibitor10.6%Farxiga59%Jardiance37%Dapagliflozin4%Part D≥55 patientsPotassium supplement2.9%Potassium Chloride89%Klor-Con M2011%Part D<11 patients+ 2 more classes in this area
Blood & clotting
4.9%Factor Xa inhibitor2.9%Eliquis78%Xarelto22%Part D<11 patientsVitamin K antagonist1%Warfarin Sodium100%Part D≥12 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-15849-ACC IMPACT OF RACE ON PERIPARTUM CARDIOMYOPATHY OUTCOMES
Journal of the American College of Cardiology
2026 - RACIAL DISPARITIES IN DIASTOLIC DYSFUNCTION IN PCOS WOMEN
Journal of the American College of Cardiology
2025 - POST-INFARCTION VENTRICULAR SEPTAL RUPTURE: NOT JUST A LATE COMPLICATION
Journal of the American College of Cardiology
2023 - OUTPATIENT INOTROPE THERAPY IN PATIENTS WITH ADVANCED HEART FAILURE - A TERTIARY CARE EXPERIENCE
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gailen Marshall, MD
University of Mississippi Medical Center
Michael Winniford, MD
University of Mississippi Medical Center
Yoshitsugu Obi, MD, PhD
University of Mississippi Medical Center
Charles Pound, MD
University of Mississippi Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”